NAT Nordic American Tankers Ltd $NAT Company Overview

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
NAT Nordic American Tankers Ltd $NAT Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=NAT&...mp;yt0=Go!

Last Updated: 08/06/2015 00:28:20

Current Price and Quotes
Last Price 15.05
Previous Close 15.00 Open 15.11
Daily Range 14.96 - 15.22 52wk Range 6.95 - 17.45
Volume 1,770,674 Dividend 1.60
Average Vol (30d) 2,296,472 Net Dividend Yield 10.6312




Financials
Period Ending Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 351,049 243,657 130,682 94,787
Cost of Revenue - - - -
Gross Profit 351,049 243,657 130,682 94,787
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 275,293 262,889 117,335 101,374
Non-Recurring Items - - 12,030 -
Other 80,531 74,375 69,219 64,626
Operating Income (4,775) (93,608) (67,902) (71,213)
Income From Continuing Operations

Add'l Income/Expense Items 2,593 (245) 564 1,045
Earnings Before Interest and Tax (2,182) (93,853) (67,338) (70,168)
Interest Expense 12,244 11,518 5,854 2,130
Earnings Before Tax (14,426) (105,371) (73,192) (72,298)
Income Tax 47 86 - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary 1,665 40 - -
Net Income Cont. Operations (12,808) (105,417) (73,192) (72,298)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,808) (105,417) (73,192) (72,298)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (12,808) (105,417) (73,192) (72,298)

Recent News

NAT Nordic American Tankers Ltd Research DD Guide

Stock Message Board http://investorshangout.com/search?q=NAT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NAT/quote
Stock Chart http://www.otcmarkets.com/stock/NAT/chart
Company Info http://www.otcmarkets.com/stock/NAT/company-info
Recent News http://www.otcmarkets.com/stock/NAT/news
Financials http://www.otcmarkets.com/stock/NAT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NAT/filings
Short Sales http://www.otcmarkets.com/stock/NAT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NAT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NAT/research
Summary http://finance.yahoo.com/q?s=NAT
Historical Prices http://finance.yahoo.com/q/hp?s=NAT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NAT
Basic Chart http://finance.yahoo.com/q/bc?s=NAT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NAT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NAT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NAT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NAT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NAT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NAT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NAT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NAT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NAT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NAT
Balance Sheet http://finance.yahoo.com/q/bs?s=NAT
Cash Flow http://finance.yahoo.com/q/cf?s=NAT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NAT
Market Watch http://www.marketwatch.com/investing/stock/NAT
Bloomberg http://www.bloomberg.com/quote/NAT:US
Morningstar http://quotes.morningstar.com/stock/s?t=NAT
Bussinessweek http://investing.businessweek.com/research/st...ticker=NAT
Barchart http://www.barchart.com/quotes/stocks/NAT
OTC Short Report http://otcshortreport.com/index.php?index=NAT
Investopedia http://www.investopedia.com/markets/stocks/NAT/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading